Rigel Pharmaceuticals (RIGL) FCF Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 631.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 631.00 |
| Dec 31, 2025 | 637.00 |
| Sep 30, 2025 | -460.00 |
| Jun 30, 2025 | 2,921.00 |
| Mar 31, 2025 | 1,530.00 |
| Dec 31, 2024 | 4,257.00 |
| Sep 30, 2024 | 4,403.00 |
| Jun 30, 2024 | -2,124.00 |
| Mar 31, 2024 | -135.00 |
| Dec 31, 2023 | 2,543.00 |
| Sep 30, 2023 | 5,537.00 |
| Jun 30, 2023 | 6,523.00 |
| Mar 31, 2023 | 13,891.00 |
| Dec 31, 2022 | 5,055.00 |
| Sep 30, 2022 | -1,161.00 |
| Jun 30, 2022 | -25,185.00 |
| Mar 31, 2022 | -12,981.00 |
| Dec 31, 2021 | -628.00 |
| Sep 30, 2021 | 5,842.00 |
| Jun 30, 2021 | 29,602.00 |
| Mar 31, 2021 | -1,808.00 |
| Dec 31, 2020 | -2,051.00 |
| Sep 30, 2020 | -3,512.00 |
| Jun 30, 2020 | 7,376.00 |
| Mar 31, 2020 | 86.00 |
| Dec 31, 2019 | -9,720.00 |
| Sep 30, 2019 | 34,411.00 |
| Jun 30, 2019 | 138,775.00 |
| Dec 31, 2018 | -41,028.00 |
| Sep 30, 2018 | 154,690.00 |
| Dec 31, 2017 | 85,652.00 |
| Sep 30, 2017 | -135,589.00 |
| Mar 31, 2017 | -12,824.00 |
| Dec 31, 2016 | -25,248.00 |
| Sep 30, 2016 | -53,186.00 |
| Jun 30, 2016 | 13,433.00 |
| Mar 31, 2016 | -127,658.00 |
| Jun 30, 2013 | -10,351.00 |
| Jun 30, 2012 | 308,483.00 |
| Sep 30, 2011 | -27,910.00 |